Yuani Hall

PHD Doctor of Philosophy,  Massachusetts General Hospital 

Location: Africa

Consulting Services

Scientific Writing Journal Manuscript Pharma-CRO-Device Admin and Customer Support Research Consulting

Areas Of Interest

Fluid, Intraocular Cyclodialysis Cleft, Persistent Voltage Gated K+ Channels Femoracetabular Impingement Charcot Marie Tooth Disease, Type IB Genetic Structures Setae AG 1749 Gammapapillomaviruses Serique, Facteur Thymique Slow Reacting Substance of Anaphylaxis Nerve Injury, Accessory Physical Phenomenon Analysis, Bibliometric Processes, Nursing Cells, Granulocyte-Macrophage Progenitor TRPC Cation Channels Absenteeism SDF-1beta Cyclin-Dependent Kinase 8 Nonrandomized Controlled Trials as Topic Medigap Policies Dioctyl Sulfosuccinate, Sodium Handovers, Clinical Glucosidases Wernicke's Encephalopathy Plants, Saline-Resistant

Professional Narrative

Dr. Yuani Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 1996
Director Medicine, Harvard Med 1991

Education

Director Medicine, Weill Medical College 1994
Master of Science in physician assistant, Harvard Medical School 2018

Referees


Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :